Alterations in GABAA receptor expression in neonatal ventral hippocampal lesioned rats: Comparison of prepubertal and postpubertal periods

Synapse

Volumn 61, Issue 6, 2007, Pages 357-366

  Endo, Kenichi ^a   Hori, Takafumi ^a   Abe, Shuzo ^a,b   Asada, Takashi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Kurita Hospital   (Japan)

Author keywords

Animal model; Development; Prefrontal cortex; Schizophrenia; Striatum; TBPS

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; IBOTENIC ACID; MESSENGER RNA; TERT BUTYLBICYCLOPHOSPHOROTHIOATE;

ADOLESCENT; ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN DAMAGE; CAUDATE NUCLEUS; CONTROLLED STUDY; GABAERGIC SYSTEM; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PREPUBERTY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PUTAMEN; QUANTITATIVE ANALYSIS; RAT; RNA ANALYSIS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANIMALS, NEWBORN; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING, COMPETITIVE; CORPUS STRIATUM; DENERVATION; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; MALE; NEURAL PATHWAYS; NEURONAL PLASTICITY; PREFRONTAL CORTEX; PROTEIN SUBUNITS; PUBERTY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RNA, MESSENGER; SCHIZOPHRENIA; UP-REGULATION;

EID: 34147170998     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20393     Document Type: Article

References (53)

1. A receptor sub-unit mRNAs and ligand binding sites in rat brain following phencyclidine administration. Synapse 38:51-60.
2. Abe S, Suzuki T, Endo K, Hori T, Arai H. 2005. Effects of single and repeated phencyclidine administration on [3H] flunitrazepam binding in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 29: 133-140.
3. A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience 75:1021-1031.
4. Bird ED, Spokes EG, Barnes J, MacKay AV, Iversen LL, Shepherd M. 1977. Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses. Lancet 2:1157-1158.
5. Bhardwaj SK, Quirion R, Srivastava LK. 2004. Post-pubertal adrenergic changes in rats with neonatal lesions of the ventral hippocampus. Neuropharmacology 46:85-94.
6. Brake WG, Sullivan RM, Flores G, Srivastava LK, Gratton A. 1999. Neonatal ventral hippocampal lesions attenuate the nucleus accumbens dopamine response to stress: an electrochemical study in the adult rat. Brain Res 831:25-32.
7. Carr DB, Sesack SR. 1996. Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopamine terminals. J Comp Neurol 369:1-15.
8. Coyle JT, Tsai G. 2004. The NMDA receptor glycine modulatory site: A therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology (Berl) 174:32-38.
9. Edgar PP, Schwartz RD. 1990. Localization and characterization of 35S-t-butylbicyclophosphorothionate binding in rat brain: an autoradiographic study. J Neurosci 10:603-612.
10. Flores G, Barbeau D, Quirion R, Srivastava LK. 1996. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus. J Neurosci 16:2020-2026.
11. Groenewegen HJ, Vermeulen-Van der Zee E, te Kortschot A, Witter MP. 1987. Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of Phaseolus vulgaris leucoagglutinin. Neuroscience 23:103-120.
12. Heimer L, Alheid G, Zaborsky L. 1995. Basal ganglia. In: Paxinos G, editor. The rat nervous system. San Diego: Academic Press. p 579-628.
13. Homanics GE, DeLorey TM, Firestone LL, Quinlan JJ, Handforth A, Harrison NL, Krasowski MD, Rick CE, Korpi ER, Makela R, Brilliant MH, Hagiwara N, Ferguson C, Snyder K, Olsen RW. 1997. Mice devoid of γ-aminobutyrate type A receptor β3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci USA 94:4143-4148.
14. Hori T, Subramaniam S, Srivastava LK, Quirion R. 2000. Behavioral and neurochemical alterations following repeated phencyclidine administration in rats with neonatal ventral hippocampal lesions. Neuropharmacology 39:2478-2491.
15. Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, Uzunov DP, Smalheiser NR, Davis JM, Pandey GN, Pappas GD, Tueting P, Sharma RP, Costa E. 1998. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 95:15718-15723.
16. A α1 and β2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Neurosci Res 50:77-84.
17. Ito T, Suzuki T, Lim DK, Wellman SE, Ho IK. 1995. A novel quantitative receptor autoradiography and in situ hybridization histochemistry technique using storage phosphor screen imaging. J Neurosci Methods 59:265-271.
18. Javitt DC, Zukin SR. 1991. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
19. Jay TM, Witter MP. 1991. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin. J Comp Neurol 313:574-586.
20. Kelley AE, Domesick VB, Nauta WJ. 1982. The amygdalostriatal projection in the rat - An anatomical study by anterograde and retrograde tracing methods. Neuroscience 7:615-630.
21. Laplante F, Srivastava LK, Quirion R. 2004. Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions. J Neurochem 89:314-323.
22. A receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J Neurosci 12:4151-4172.
23. Lewis DA, Volk DW, Hashimoto T. 2004. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: A novel target for the treatment of working memory dysfunction. Psychopharmacology (Berl) 174:143-150.
24. Lewis DA, Hashimoto T, Volk DW. 2005. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6:312-324.
25. Lieberman JA, Koreen AR. 1993. Neurochemistry and neuroendocrinology of schizophrenia: A selective review. Schizophr Bull 19: 371-429.
26. Lillrank SM, Lipska BK, Kolachana BS, Weinberger DR. 1999. Attenuated extracellular dopamine levels after stress and amphetamine in the nucleus accumbens of rats with neonatal ventral hippocampal damage. J Neural Transm 106:183-196.
27. Lipska BK, Weinberger DR. 2000. To model a psychiatric disorder in animals: Schizophrenia as a reality test. Neuropsychopharmacology 23:223-239.
28. Lipska BK, Jaskiw GE, Weinberger DR. 1993. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia. Neuropsychopharmacology 9:67-75.
29. Lipska BK, Chrapusta SJ, Egan MF, Weinberger DR. 1995. Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol. Synapse 20:125-130.
30. Lipska BK, al-Amin HA, Weinberger DR. 1998. Excitotoxic lesions of the rat medial prefrontal cortex. Effects on abnormal behaviors associated with neonatal hippocampal damage. Neuropsychopharmacology 19:451-464.
31. Lipska BK, Aultman JM, Verma A, Weinberger DR, Moghaddam B. 2002. Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology 27:47-54.
32. Lipska BK, Lerman DN, Khaing ZZ, Weickert CS, Weinberger DR. 2003. Gene expression in dopamine and GABA systems in an animal model of schizophrenia: Effects of antipsychotic drugs. Eur J Neurosci 18:391-402.
33. A-receptor expressed from rat brain α- and β-subunit cDNAs displays potentiation by benzodiazepine receptor ligands. Brain Res Mol Brain Res 8:199-208.
34. A-receptor subtypes really occur in the brain? Trends Neurosci 19:139-143.
35. Mitchell CP, Grayson DR, Goldman MB. 2005. Neonatal lesions of the ventral hippocampal formation alter GABA-A receptor subunit mRNA expression in adult rat frontal pole. Biol Psychiatry 57:49-55
36. O'Donnell P, Lewis BL, Weinberger DR, Lipska BK. 2002. Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats. Cereb Cortex 12:975-982.
37. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates, 2nd ed. Orlando: Academic Press.
38. A receptor β3 subunit knockout mice. J Neurochem 73:1539-1548.
39. Reynolds DS, O'Meara GF, Newman RJ, Bromidge FA, Atack JR, Whiting PJ, Rosahl TW, Dawson GR. 2003. GABA(A) α1 subunit knock-out mice do not show a hyperlocomotor response following amphetamine or cocaine treatment. Neuropharmacology 44:190-198
40. Schroeder H, Grecksch G, Becker A, Bogerts B, Hoellt V. 1999. Alterations of the dopaminergic and glutamatergic neurotransmission in adult rats with postnatal ibotenic acid hippocampal lesion. Psychopharmacology (Berl) 145:61-66.
41. Sesack SR, Pickel VM. 1990. In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res 527:266-279.
42. Sieghart W. 1995. Structure and pharmacology of γ-aminobutyric acidA receptor subtypes. Pharmacol Rev 47:181-234.
43. Spanagel R, Weiss F. 1999. The dopamine hypothesis of reward: Past and current status. Trends Neurosci 22:521-527.
44. 35S]t-butylbicyclophosphorothionate binds with high affinity to brain-specific sites coupled to γ-aminobutyric acid-A and ion recognition sites. Mol Pharmacol 23:326-336.
45. A receptor subtype in the brain is not lethal in mice. J Neurosci 21:3409-3418.
46. A-benzodiazepine receptor complexes. Synapse 38:198-215.
47. Tzschentke TM. 2001. Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol 63:241-320.
48. Wan RQ, Giovanni A, Kafka SH, Corbett R. 1996. Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies. Behav Brain Res 78: 211-223.
49. Wan RQ, Hartman H, Corbett R. 1998. Alteration of dopamine metabolites in CSF and behavioral impairments induced by neonatal hippocampal lesions. Physiol Behav 65:429-436.
50. Weinberger DR. 1996. On the plausibility of "the neurodevelopmental hypothesis" of schizophrenia. Neuropsychopharmacology 14: 1S-11S.
51. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 12:1040-1062.
52. Woo TU, Whitehead RE, Melchitzky DS, Lewis DA. 1998. A subclass of prefrontal γ-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 95:5341-5346.
53. A receptor β subunit heterogeneity: functional expression of cloned cDNAs. EMBO J 8:1665-1670.